drugset / Trial / NCT07626437
Fixed-dose Combination of 1000 mg Dipyrone Monohydrate + 60 mg Caffeine + 4 mg Chlorpheniramine Maleate in Improving Symptoms of the Common Cold and Flu in Adults
RandomizedParallel-groupDouble-blindTreatment
Summary
Phase III clinical trial to evaluate the efficacy and safety of a fixed-dose combination of 1000 mg dipyrone monohydrate + 60 mg caffeine + 4 mg chlorpheniramine maleate in improving symptoms of the common cold and flu in adults.
Timeline
- Start
- 2026-05-08
- Primary completion
- 2027-06-28
- Completion
- 2027-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Caffeine | Small molecule | 30 mg | — |
| Comparator | Caffeine | Small molecule | 60 mg | — |
| Comparator | Chlorpheniramine | Unknown | 2 mg | — |
| Comparator | Chlorpheniramine | Unknown | 4 mg | — |
| Comparator | dipyrone | Unknown | 500 mg | — |
| Comparator | dipyrone | Unknown | 1000 mg | — |